The Blood Proteome Predicts High Risk of Relapse in Mantle Cell Lymphoma Patients

In this Swedish study, Patrick Nylund, Cancer Precision Medicine Unit, Uppsala University, explains how novel biomarkers can provide insight into the prognostic capabilities of the blood proteome in mantle cell protein and predict a high risk of relapse in mantle cell lymphoma patients.